↓ Skip to main content

ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-bl…

Overview of attention for article published in Arthritis Research & Therapy, October 2020
Altmetric Badge

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial
Published in
Arthritis Research & Therapy, October 2020
DOI 10.1186/s13075-020-02336-3
Pubmed ID
Authors

Tsutomu Takeuchi, Yoshiya Tanaka, Jay Erdman, Yuichiro Kaneko, Masako Saito, Chieri Higashitani, Ronald Smulders, Christopher Lademacher

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 17%
Student > Bachelor 4 11%
Researcher 4 11%
Student > Doctoral Student 2 6%
Other 2 6%
Other 6 17%
Unknown 12 33%
Readers by discipline Count As %
Medicine and Dentistry 10 28%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Biochemistry, Genetics and Molecular Biology 2 6%
Unspecified 2 6%
Nursing and Health Professions 2 6%
Other 4 11%
Unknown 13 36%